Impact of lung transplantation on serum lipids in adults with cystic fibrosis

Journal of Heart and Lung Transplantation

Volumn 30, Issue 2, 2011, Pages 188-193

  Nash, Edward F ^a,b   Stephenson, Anne ^b   Helm, Emma J ^c   Durie, Peter R ^d,e   Tullis, Elizabeth ^b,f   Singer, Lianne G ^a   Chaparro, Cecilia ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

calcineurin inhibitor; cystic fibrosis; hyperlipidemia; lipids; lung transplantation

Indexed keywords

CYCLOSPORIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TACROLIMUS;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CYSTIC FIBROSIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; COHORT STUDIES; CYCLOSPORINE; CYSTIC FIBROSIS; FEMALE; GRAFT REJECTION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE AGENTS; LIPIDS; LUNG TRANSPLANTATION; MALE; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 78650942225     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.08.024     Document Type: Article

References (25)

1. P.B. Pencharz, and P.R. Durie Pathogenesis of malnutrition in cystic fibrosis, and its treatment Clin Nutr 19 2000 387 394
2. C.M. Gordon, E.J. Anderson, and K. Herlyn Nutrient status of adults with cystic fibrosis J Am Diet Assoc 107 2007 2114 2119
3. V. Figueroa, C. Milla, and E.J. Parks Abnormal lipid concentrations in cystic fibrosis Am J Clin Nutr 75 2002 1005 1011
4. E. Levy, C. Gurbindo, and F. Lacaille Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis Pediatr Res 34 1993 162 166
5. B. Rhodes, E.F. Nash, and E. Tullis Prevalence of dyslipidemia in adults with cystic fibrosis J Cyst Fibros 9 2010 24 28
6. B.P. O'Sullivan, and S.D. Freedman Cystic fibrosis Lancet 373 2009 1891 1904
7. J.D. Christie, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report2008 J Heart Lung Transplant 27 2008 957 969
8. L.R. Tannock, and L.R. Reynolds Management of dyslipidemia in patients after solid organ transplantation Postgrad Med 120 2008 43 49
9. A. Sessa, A. Esposito, and A. Giliberti Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients Transplant Proc 41 2009 1178 1182
10. C. Fernndez-Miranda, C. Guijarro, and A. de la Calle Lipid abnormalities in stable liver transplant recipientseffects of cyclosporine, tacrolimus and steroids Transplant Int 11 1998 137 142
11. R. Marcn, J. Chahin, and A. Alarcn Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study Transplant Proc 38 2006 2427 2430
12. M. Silverborn, A. Jeppsson, and G. Mrtensson New-onset cardiovascular risk factors in lung transplant recipients J Heart Lung Transplant 24 2005 1536 1543
13. R. McPherson, J. Frohlich, and G. Fodor Canadian Cardiovascular Society position statementrecommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease Can J Cardiol 22 2006 913 927
14. P.W. Wilson, W.P. Castelli, and W.B. Kannel Coronary risk prediction in adults (the Framingham Heart Study) Am J Cardiol 59 1987 91G 94G
15. S.M. Haffner Management of dyslipidemia in adults with diabetes Diabetes Care 26 suppl 1 2003 S83 S86
16. D.O. Taylor, M.L. Barr, and B. Radovancevic A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 18 1999 336 345
17. G. Ligtenberg, R.J. Hene, and P.J. Blankestijn Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus J Am Soc Nephrol 12 2001 368 373
18. M.A. Artz, J.M. Boots, and G. Ligtenberg Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile Am J Transplant 4 2004 937 945
19. J.P. van Hooff, M.H. Christiaans, and E.M. van Dujinhoven Tacrolimus and posttransplant diabetes mellitus in renal transplantation Transplantation 79 2005 1465 1469
20. G.M. Onady, and C.L. Farinet An adult cystic fibrosis patient presenting with persisting dyspnea: case report BMC Pulm Med 8 2006 9
21. D.M. Lyu, and M.R. Zamora Medical complications of lung transplantation Proc Am Thorac Soc 6 2009 101 107
22. L. Huiart, P. Ernst, and X. Ranouil Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease Can Respir J 13 2006 134 138
23. T.H. Hostetter Chronic kidney disease predicts cardiovascular disease N Engl J Med 351 2004 1344 1346
24. B.R. Stephany, B. Alao, and M. Budev Hyperlipidemia is associated with accelerated chronic kidney disease progression after lung transplantation Am J Transplant 7 2007 2553 2560
25. B.A. Johnson, A.T. Iacono, and A. Zeevi Statin use is associated with improved function and survival in lung allografts Am J Crit Care Med 167 2003 1271 1278